drugset / Trial / NCT00360269
Atomoxetine Treatment for ADHD and Marijuana Dependence
Phase 2
Completed
38 enrolled
Medical University of South Carolina
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of the study is to determine if atomoxetine treatment combined with motivational enhancement therapy is effective in reducing marijuana use in adult individuals with attention-deficit hyperactivity disorder and marijuana dependence.
Timeline
- Start
- 2005-11
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atomoxetine | Other / unclassified | 25 mg | — |
| Subject | Atomoxetine | Other / unclassified | 100 mg | — |